Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in Psoriatic Arthritis
NCT02188654Completed
- Sponsor
- Alexandria University
- Start
- Sep 2013
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in psoriatic arthritis (PsA) comparing Metformin with Placebo (2 arms). Primary endpoint: ACR 20% Response at 24 weeks. Started Sep 2013; status: completed.
02
Drugs
metformin
03
Conditions
psoriatic arthritis (PsA)
Beyond the preview
Go deeper on NCT02188654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02188654.